FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships

Iterum Therapeutics plc received FDA approval for Orlynvah to treat uncomplicated urinary tract infections in adult women. This marks a significant milestone for Iterum and offers a new treatment option for patients.